Winterized CBDa Crude Oil

us hemp&oil logo.png
To speak with us directly, please call:  352.421.9794 

Full-spectrum CBDa crude oils are often praised for their ability to closely replicate the chemical composition of the hemp plant. All CBD begins as CBDa and turns to CBD as the plant matures. Our extraction process at US Hemp and Oil protects the CBDa so our final product is an ideal blend of both CBD and CBDa. This cannabinoid profile is garnering attention for its potential to boost immune systems as well as reduce inflammation and anxiety.

At USHO, our CBDa will be 2x the cost of regular CBD crude oil since it takes us twice as long to create. For example, if a customer bought a kilo of crude at 100.00; a kilo of CBDa will be 200.00.  

*Flavor profiles variation are dependent on carrier oil.

**(N/D) Non-Detect Disclaimer: THC is inherently present in trace amounts in hemp plants. We test our products to confirm that the presence of Δ-9-Tetrahydrocannabinol (Δ-9-THC) and Tetrahydrocannabinolic Acid (THCA) are non-detectable (none detected above the requisite limits of detection for each product type); however sensitivities of drug testing methodologies may vary.

What is CBDA?

Full-spectrum CBDa crude oil is considered a true hemp oil since it contains all of its original naturally-occurring compounds. Full-spectrum CBDa crude oil is high in CBDa but also includes all cannabinoids, terpenes, flavonoids, phytochemical compounds, natural minerals, and other bioactive compounds. The CBDa molecule is not changed to CBD during a decarboxylation process.



Research is showing CBDA may have enhanced immune boosters that were effective in a Oregon State University study published in 2022: "In follow-up virus neutralization assays, cannabigerolic acid and cannabidiolic acid [CBDa] prevented infection of human epithelial cells by a pseudovirus expressing the SARS-CoV-2 spike protein and prevented entry of live SARS-CoV-2 into cells. Importantly, cannabigerolic acid and cannabidiolic acid [CBDa] were equally effective against the SARS-CoV-2 alpha variant B.1.1.7 and the beta variant B.1.351. Orally bioavailable and with a long history of safe human use, these cannabinoids, isolated or in hemp extracts, have the potential to prevent as well as treat infection by SARS-CoV-2. ("